Kerry Acquires Biothera and Wellmune Immune-Health Ingredient
Wellmune is used in both food and supplement products.
Photo © iStockphoto.com/webphotographeer
Food Ingredients and flavor firm Kerry Group plc (Tralee, Ireland) has acquired Biothera Inc. (Eagan, MN), a supplier best known for its trademark immune-health beta-glucan ingredient Wellmune. The ingredient is used in both food and supplement products.
“The addition of Wellmune to our portfolio offers Kerry tremendous growth opportunities globally,” said Michael O’Neill, Nutrition President, Kerry, in a press release. “This natural immunity enhancer strengthens our nutrition and general wellness capabilities and complements our taste solutions for applications in food, beverages, and supplements.”
“The combination of Biothera’s technology and Kerry’s leadership in R&D, nutritional science, and forward-looking market insights will advance the science of immune health and create new and innovative food, beverages, and supplements,” said Biothera CEO Richard G. Mueller.
Jennifer Grebow
Editor-in-Chief
Nutritional Outlook magazine
jennifer.grebow@ubm.com
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
